Formulation
Four plant-derived components, selected from published literature and designed as one system.
We develop phytogenic feed-delivered nutrition for commercial poultry — from formulation through evaluation with mills, producers, and research partners, without claims the evidence does not yet support.
Four plant-derived components, selected from published literature and designed as one system.
We publish where development stands, what is still open, and how we handle claims.
The intended route is ordinary commercial poultry feed — no new farm-level administration system.
Analytical and stability work first. Controlled biological evaluation only in qualified facilities.
Primary program
NeuraNext has explored multiple research areas, but the company’s active commercial-development focus is poultry nutrition. We are building a phytogenic poultry-feed additive for ordinary commercial rations — formulation, analytical methods, stability, and partnerships with mills, labs, and producers.
How we build
We do not skip steps. Formulation stability comes before biological evaluation, and evaluation comes before any claim we would put in front of a customer. The sequence is on the progress page.
Year 1 · In progress
Supplier qualification, analytical methods, prototypes, and a stability program.
Year 2
Inclusion rates, palatability and tolerance, and repeatable pilot batches.
Year 3
Controlled evaluation in qualified facilities, then a lawful claim set.
Year 4
Producer evaluation, contract manufacturing, and batch-release controls.
Year 5
Recurring manufacture and distribution through existing feed channels.
How we work with you
We are not a clinic and not a mill. We develop poultry-feed nutrition meant to run through existing commercial feed channels. Nothing on this site is for sale yet.
01
Arizona LLC, formed in 2024. We do not provide veterinary or medical care.
02
The feed program is designed for ordinary commercial rations, not a new farm system.
03
We do not sell unfinished product. Evaluation work comes first.
04
No disease, device, or performance claim until generated evidence and regulation allow it.
Leadership
Oluwatunde A. Aderounmu, DVM, MBA, PMP leads the company. He is a veterinarian who has taken phytogenic poultry-feed products through to commercial manufacture. That is the background we bring to this work. About the founder.
Exploratory research
NeuraNext has also explored early-stage neurotechnology concepts related to spinal-cord injury. This work remains exploratory and is not the company’s current commercial development focus. Read more about this research line.
Mills, producers, and laboratories
We are looking for the partners who will help build and evaluate this work. Nothing is available for purchase.